These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9740921)

  • 41. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology.
    Meltzer EO; Orgel HA; Bronsky EA; Furukawa CT; Grossman J; LaForce CF; Lemanske RF; Paull BD; Pearlman DS; Ratner PH
    J Allergy Clin Immunol; 1990 Aug; 86(2):221-30. PubMed ID: 2200821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis.
    Banov CH; Woehler TR; LaForce CF; Pearlman DS; Blumenthal MN; Morgan WF; Frazer H; Southern DL; Gold B; Field E
    Ann Allergy; 1994 Sep; 73(3):240-6. PubMed ID: 8092559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects.
    Howland WC; Hampel FC; Martin BG; Ratner PH; van Bavel JH; Field EA
    Clin Ther; 1996; 18(6):1106-17. PubMed ID: 9001827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
    Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluticasone furoate nasal spray: effective monotherapy for symptoms of perennial allergic rhinitis in adults/adolescents.
    Vasar M; Houle PA; Douglass JA; Meltzer EO; Silvey M; Wu W; Caldwell M; Philpot E
    Allergy Asthma Proc; 2008; 29(3):313-21. PubMed ID: 18442449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of fluticasone on neuropeptides in nasal lavage in persistent allergic rhinitis.
    Schäper C; Gustavus B; Koch B; Ewert R; Felix SB; Kunkel G; Noga O; Gläser S
    J Investig Allergol Clin Immunol; 2010; 20(3):214-21. PubMed ID: 20635787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
    Karaki M; Akiyama K; Mori N
    Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia.
    Webb DR; Meltzer EO; Finn AF; Rickard KA; Pepsin PJ; Westlund R; Cook CK
    Ann Allergy Asthma Immunol; 2002 Apr; 88(4):385-90. PubMed ID: 11995670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
    Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.
    Nathan RA; Berger W; Yang W; Cheema A; Silvey M; Wu W; Philpot E
    Ann Allergy Asthma Immunol; 2008 May; 100(5):497-505. PubMed ID: 18517084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative study between fluticasone propionate and cetirizine in the treatment of allergic rhinitis.
    D'Ambrosio FP; Gangemi S; Merendino RA; Arena A; Ricciardi L; Bagnato GF
    Allergol Immunopathol (Madr); 1998; 26(6):277-82. PubMed ID: 9934406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis.
    Hughes K; Glass C; Ripchinski M; Gurevich F; Weaver TE; Lehman E; Fisher LH; Craig TJ
    Allergy; 2003 May; 58(5):380-5. PubMed ID: 12797340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An association between acquired epiphora and the signs and symptoms of chronic rhinosinusitis: a prospective case-control study.
    Annamalai S; Kumar NA; Madkour MB; Sivakumar S; Kubba H
    Am J Rhinol; 2003; 17(2):111-4. PubMed ID: 12751707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Presence of fluticasone propionate on human nasal mucosal surface and in human nasal tissue over a period of 24 h after intranasal application.
    Bonsmann U; Bachert C; Delank KW; Rohdewald P
    Allergy; 2001 Jun; 56(6):532-5. PubMed ID: 11421898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acoustic evaluation of the efficacy of medical therapy for allergic nasal obstruction.
    Yamagiwa M
    Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S82-4. PubMed ID: 9065635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CT assessment of the effect of fluticasone propionate aqueous nasal spray treatment on lower turbinate hypertrophy due to vasomotor rhinitis.
    Arikan OK; Koc C; Kendi T; Muluk NB; Ekici A
    Acta Otolaryngol; 2006 Jan; 126(1):37-42. PubMed ID: 16308253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic, noninfectious perennial rhinitis.
    Blom HM; Godthelp T; Fokkens WJ; KleinJan A; Mulder PG; Rijntjes E
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):739-47. PubMed ID: 9438480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal spray.
    Shah SR; Miller C; Pethick N; Uryniak T; Jones MK; O'Dowd L
    Clin Ther; 2003 Aug; 25(8):2198-214. PubMed ID: 14512128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new drug for managing both nasal and ocular symptoms of allergic rhinitis: fluticasone furoate nasal spray.
    Enoz M; Inancli HM; Lapeña JF; Hafiz G
    Int J Pediatr Otorhinolaryngol; 2011 Jan; 75(1):140. PubMed ID: 20223526
    [No Abstract]   [Full Text] [Related]  

  • 60. Nasolacrimal duct orifice cysts in adults: a previously unrecognized, easily treatable cause of epiphora.
    DelGaudio JM; Wojno T
    Laryngoscope; 2007 Oct; 117(10):1830-3. PubMed ID: 17690605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.